Objective To investigate the role of FHIT, cyclinD 1, CDK 4 in NSCLC.
目的研究非小细胞肺癌(NSCLC) 中脆弱性组氨酸三联体(FHIT) 、 细胞周期素D1(cyclinD1) 、 细胞周期蛋白依赖激酶4(CDK4)的表达与NSCLC发生发展的关系.
互联网
Median survival in the patients with SCLC was 3 months, with NSCLC was 8 . 5 months.
SCLC和NSCLC的中位生存期分别为3个月和8.5个月.
互联网
The results were confirmed using two additional adenocarcinoma NSCLC and two nonadenocarcinoma NSCLC cell lines.
用另外两种NSCLC的腺癌细胞株和两种NSCLC的 非腺癌细胞株也证实了这种结果.
互联网
Methods A total of 110 caes with advanced NSCLC were enrolled in study.
方法110例晚期NSCLC患者.
互联网
Methods NSCLC from 113 patients were analyzed immunohistochemically with antibodies to neuro | specific enolase ( NSE ), synaptophysin ( SYN ) and chromogranin, ( CgA ).
方法 采用SP免疫 组化法检测113例NSCLC中神经元特异性烯醇化酶 ( NSE ) 、 突触素 ( SYN ) 和嗜铬素A ( CgA ) 的表达.
互联网
This patient is thus an excellent candidate for a platinum - based regimen for his NSCLC.
因此这位NSCLC患者是采用含铂方案治疗的极佳人选.
互联网
Methods : To review the benefit : risk profile of Gefitinib and Erlotinib in Asian patients with advanced NSCLC.
目的回顾性分析亚裔晚期NSCLC患者使用 吉非 替尼的临床研究,了解亚裔患者使用吉非替尼后的疗效与毒性反应.
互联网
Keyword: ZD 1839 NSCLC Disease control rates Adverse events.
关键词: ZD1839非小细胞肺癌疾病控制率不良事件.
互联网
Objective To evaluate the effectiveness andthe second - line treatment on patients with advanced non - small cell lung cancer ( NSCLC ).
结论多西他赛单药二线治疗晚期 非 小细胞肺癌疗效肯定,耐受性较好.
互联网
The main pathology type is small cell lung cancer ( SCLC ) and non - small cell lung cancer ( NSCLC ).
病理类型以小细胞肺癌和 非 小细胞肺癌为主.
互联网
Objectives To study the expression of CD 44 V 6 and its significance in non small cell lung carcinoma ( NSCLC ) .
目的探讨 CD44V6 在非小细胞肺癌中的表达及意义.
互联网
Objective To explore the nursing of harmful side effects of Alimta in treating terminal NSCLC.
目的探讨新药力比泰治疗晚期非小细胞肺癌毒副反应的对症护理措施.
互联网
Results: During a 2 - year period, 32 patients, 27 with NSCLC and 5 with pulmonary metastases, SRS.
结果: 在两年时期内, 32例患者, 其中27例为非小细胞肺癌,5例为肺转移, 都行SRS治疗.
互联网
Conclusions Our five - gene signature is closely associated with relapse - free and overall survival among patients with NSCLC.
结论:我们的五个基因标记与非小细胞肺癌患者的无复发及总生存率密切相关.
互联网
RESULTS: The expressive rate of EMMPRIN and ECE was 66 % and 45 %, respectively.
结果: 77例NSCLC组织 中EMMPRIN和ECE的阳性表达率分别为66%和45%.
互联网